CORT |
Corcept Therapeutics Incorporated |
7.47B |
5.47% |
|
|
|
|
|
70.82 |
-1.47% |
65.42% |
36.42% |
---|
BMY |
Bristol-Myers Squibb Company |
101.19B |
4.38% |
|
|
|
|
|
49.73 |
-0.95% |
42.70% |
60.71% |
---|
ITCI |
INTRA CELLULAR THERAPIES INC |
|
4.32% |
|
|
|
|
|
|
|
|
|
---|
JAZZ |
Jazz Pharmaceuticals plc |
7.14B |
4.22% |
|
|
|
|
|
115.86 |
-0.94% |
31.17% |
65.04% |
---|
VTRS |
Viatris Inc. |
10.21B |
4.04% |
|
|
|
|
|
8.55 |
1.54% |
30.87% |
74.08% |
---|
CTLT |
CATALENT INC |
|
4.00% |
|
|
|
|
|
|
|
|
|
---|
AXSM |
Axsome Therapeutics, Inc. |
5.43B |
3.72% |
|
|
|
|
|
111.33 |
-0.85% |
49.12% |
29.52% |
---|
PRGO |
Perrigo Company plc |
3.45B |
3.57% |
|
|
|
|
|
25.28 |
-1.71% |
43.05% |
68.58% |
---|
TARS |
Tarsus Pharmaceuticals, Inc. |
2.08B |
3.48% |
|
|
|
|
|
50.07 |
-3.54% |
72.63% |
25.46% |
---|
EWTX |
Edgewise Therapeutics, Inc. |
1.75B |
3.46% |
|
|
|
|
|
16.64 |
1.46% |
89.13% |
12.77% |
---|
RPRX |
Royalty Pharma plc |
14.04B |
3.39% |
|
|
|
|
|
32.39 |
-1.31% |
31.94% |
48.25% |
---|
PFE |
Pfizer Inc. |
135.75B |
3.38% |
|
|
|
|
|
23.94 |
-1.94% |
39.52% |
46.99% |
---|
ZTS |
Zoetis Inc. |
69.64B |
3.34% |
|
|
|
|
|
156.13 |
-0.17% |
29.70% |
65.83% |
---|
JNJ |
Johnson & Johnson |
371.98B |
3.31% |
|
|
|
|
|
154.36 |
-1.25% |
22.59% |
34.98% |
---|
MRK |
Merck & Co., Inc. |
210.17B |
3.24% |
|
|
|
|
|
83.52 |
-1.97% |
41.05% |
63.29% |
---|
ELAN |
Elanco Animal Health Incorporated |
4.71B |
3.20% |
|
|
|
|
|
9.50 |
0.16% |
53.28% |
42.03% |
---|
LLY |
Eli Lilly and Company |
761.19B |
3.18% |
|
|
|
|
|
802.95 |
-10.68% |
43.54% |
44.90% |
---|
OGN |
Organon & Co. |
2.45B |
2.69% |
|
|
|
|
|
9.43 |
-27.11% |
45.12% |
65.39% |
---|
PBH |
Prestige Consumer Healthcare Inc. |
4.07B |
2.65% |
|
|
|
|
|
82.14 |
1.12% |
28.23% |
65.20% |
---|
PCRX |
Pacira BioSciences, Inc. |
1.23B |
2.53% |
|
|
|
|
|
26.63 |
-1.00% |
55.77% |
19.93% |
---|
SUPN |
Supernus Pharmaceuticals, Inc. |
1.79B |
2.36% |
|
|
|
|
|
32.14 |
-1.05% |
43.71% |
39.14% |
---|
ARVN |
Arvinas, Inc. |
491.38M |
2.11% |
|
|
|
|
|
7.15 |
-25.73% |
150.95% |
27.89% |
---|
LGND |
Ligand Pharmaceuticals Incorporated |
2.09B |
2.01% |
|
|
|
|
|
108.62 |
-1.13% |
51.23% |
67.38% |
---|
AMPH |
Amphastar Pharmaceuticals, Inc. |
1.14B |
1.99% |
|
|
|
|
|
24.09 |
-1.31% |
55.34% |
75.57% |
---|
COLL |
Collegium Pharmaceutical, Inc. |
860.17M |
1.66% |
|
|
|
|
|
26.77 |
-0.83% |
55.89% |
42.38% |
---|
ANIP |
ANI Pharmaceuticals, Inc. |
1.52B |
1.59% |
|
|
|
|
|
70.25 |
-0.80% |
50.20% |
67.44% |
---|
OCUL |
Ocular Therapeutix, Inc. |
1.34B |
1.44% |
|
|
|
|
|
8.44 |
1.70% |
132.65% |
39.74% |
---|
HRMY |
Harmony Biosciences Holdings, Inc. |
1.72B |
1.35% |
|
|
|
|
|
30.02 |
1.87% |
54.28% |
68.91% |
---|
AMRX |
Amneal Pharmaceuticals, Inc. |
3.54B |
1.32% |
|
|
|
|
|
7.62 |
-0.59% |
67.35% |
79.44% |
---|
FULC |
Fulcrum Therapeutics, Inc. |
218.35M |
1.25% |
|
|
|
|
|
4.05 |
5.06% |
141.59% |
48.60% |
---|
WVE |
Wave Life Sciences Ltd. |
1.18B |
1.22% |
|
|
|
|
|
7.68 |
-0.52% |
317.00% |
35.96% |
---|
MNMD |
Mind Medicine (MindMed) Inc. |
493.29M |
1.18% |
|
|
|
|
|
6.55 |
2.43% |
97.75% |
19.38% |
---|
LQDA |
Liquidia Corporation |
1.20B |
1.09% |
|
|
|
|
|
14.09 |
0.86% |
66.08% |
36.28% |
---|
PLRX |
Pliant Therapeutics, Inc. |
96.68M |
1.06% |
|
|
|
|
|
1.5750 |
-0.94% |
117.25% |
39.13% |
---|
HROW |
Harrow Health, Inc. |
897.32M |
1.03% |
|
|
|
|
|
24.46 |
-1.25% |
89.52% |
51.41% |
---|
INVA |
Innoviva, Inc. |
1.17B |
1.02% |
|
|
|
|
|
18.57 |
-0.64% |
52.77% |
43.58% |
---|
NMRA |
Neumora Therapeutics, Inc. Common Stock |
118.76M |
0.82% |
|
|
|
|
|
0.7342 |
-5.85% |
105.51% |
50.00% |
---|
EYPT |
EyePoint Pharmaceuticals, Inc. |
481.79M |
0.79% |
|
|
|
|
|
7.01 |
2.79% |
103.49% |
31.88% |
---|
ELVN |
Enliven Therapeutics, Inc. |
957.79M |
0.67% |
|
|
|
|
|
19.55 |
3.19% |
78.13% |
35.89% |
---|
NUVB |
Nuvation Bio Inc. |
755.23M |
0.64% |
|
|
|
|
|
2.2300 |
-0.89% |
256.22% |
29.99% |
---|
EOLS |
Evolus, Inc. |
736.25M |
0.56% |
|
|
|
|
|
11.42 |
0.18% |
71.45% |
49.57% |
---|
XERS |
Xeris Biopharma Holdings, Inc. |
688.88M |
0.56% |
|
|
|
|
|
4.48 |
-2.08% |
186.20% |
92.56% |
---|
PHAT |
Phathom Pharmaceuticals, Inc. |
236.80M |
0.49% |
|
|
|
|
|
3.40 |
-20.75% |
143.88% |
62.80% |
---|
SAVA |
Cassava Sciences, Inc. |
77.05M |
0.28% |
|
|
|
|
|
1.5950 |
2.24% |
190.39% |
16.04% |
---|
|
SSI US GOV MONEY MARKET CLASS |
|
N/A |
|
|
|
|
|
|
|
|
|
---|